carbostyril has been researched along with Idiopathic Parkinson Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (11.11) | 18.2507 |
| 2000's | 10 (55.56) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 1 (5.56) | 2.80 |
| Authors | Studies |
|---|---|
| Choudhary, M; Malek, G | 1 |
| Glenmullen, J; Mattison, DR; Moore, TJ | 1 |
| Azorin, JM; Camus, V; Costentin, J; Crocq, MA; Daléry, J; Gliskman, J; Krebs, MO; Limosin, F; Millet, B | 1 |
| Schwankhaus, J; Singh, S | 1 |
| Chen, CK; Wu, JH | 1 |
| Fujino, J; Tabushi, K; Tanaka, H; Taniguchi, N | 1 |
| Chou, YH; Wang, SJ; Wu, CL; Yang, KC | 1 |
| Bouckaert, F; De Schutter, P; Peuskens, J | 1 |
| Miranda C, M; Retamal C, P | 1 |
| Connemann, BJ; Schönfeldt-Lecuona, C | 1 |
| Katz, IR | 1 |
| López-Meza, E; Ramirez-Bermudez, J; Ruiz-Chow, A | 1 |
| Ali, IM; Morris, HR; Wickremaratchi, M | 1 |
| Berman, RM; Carson, WH; Factor, SA; Friedman, JH; Goetz, CG; Marcus, RN; Ondo, WG; Wojcieszek, J | 1 |
| Singh Ajit, S | 1 |
| Hurtig, HI; Weintraub, D | 1 |
| Asin, KE; Domino, EF; Nikkel, A; Shiosaki, K | 1 |
| Konieczny, J; Lorenc-Koci, E; Ossowska, K; Wolfarth, S | 1 |
4 review(s) available for carbostyril and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
The Aryl Hydrocarbon Receptor: A Mediator and Potential Therapeutic Target for Ocular and Non-Ocular Neurodegenerative Diseases.
Topics: Animals; Basic Helix-Loop-Helix Transcription Factors; Biotransformation; Central Nervous System; Cytochrome P-450 Enzyme System; Disease Models, Animal; Eye Diseases; Eye Proteins; Gene Expression Regulation; Helix-Loop-Helix Motifs; Humans; Ligands; Mammals; Molecular Targeted Therapy; Multiple Sclerosis; Nerve Degeneration; Nerve Tissue Proteins; Neurodegenerative Diseases; Parkinson Disease; Polychlorinated Dibenzodioxins; Quinolones; Rats; Receptors, Aryl Hydrocarbon; Signal Transduction; Transcription, Genetic; Xenobiotics | 2020 |
[Clinical potentialities and perspectives for the use of aripiprazole in other disorders than its classical indications. A critical analysis of the recent literature].
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Aripiprazole; Borderline Personality Disorder; Depressive Disorder, Major; Humans; Mental Disorders; Neurodegenerative Diseases; Parkinson Disease; Piperazines; Quinolones; Schizophrenia; Substance-Related Disorders; Tourette Syndrome | 2008 |
Optimizing atypical antipsychotic treatment strategies in the elderly.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Controlled Clinical Trials as Topic; Dementia; Dibenzothiazepines; Humans; Olanzapine; Parkinson Disease; Piperazines; Psychotic Disorders; Quetiapine Fumarate; Quinolones; Risperidone; Thiazoles; Treatment Outcome | 2004 |
Presentation and management of psychosis in Parkinson's disease and dementia with Lewy bodies.
Topics: Aged; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Cholinesterase Inhibitors; Clozapine; Controlled Clinical Trials as Topic; Dibenzothiazepines; Humans; Lewy Body Disease; Male; Parkinson Disease; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quetiapine Fumarate; Quinolones | 2007 |
14 other study(ies) available for carbostyril and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs.
Topics: Adult; Aged; Aripiprazole; Benzothiazoles; Compulsive Behavior; Consumer Behavior; Dopamine Agonists; Drug Labeling; Female; Gambling; Humans; Hyperprolactinemia; Impulsive Behavior; Indoles; Male; Middle Aged; Parkinson Disease; Piperazines; Pramipexole; Quinolones; Receptors, Dopamine D3; Restless Legs Syndrome; Retrospective Studies; Sexual Behavior; United States; United States Food and Drug Administration | 2014 |
Olfactory disturbance in Parkinson disease.
Topics: Aged; Anticonvulsants; Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Biomarkers; Brain; Cognition Disorders; Constipation; Diagnosis, Differential; Disease Progression; Electroencephalography; Hallucinations; Humans; Levetiracetam; Lewy Body Disease; Male; Olfactory Pathways; Parkinson Disease; Piperazines; Piracetam; Quinolones; REM Sleep Behavior Disorder; Treatment Failure; Tremor | 2009 |
Improvement of risperidone-related tardive parkinsonism with a switch to aripiprazole.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Female; Humans; Middle Aged; Parkinson Disease; Piperazines; Quinolones; Risperidone | 2009 |
Effectiveness of aripiprazole in a patient with presumed idiopathic Parkinson's disease and chronic paranoid schizophrenia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Aripiprazole; Chronic Disease; Drug Interactions; Female; Humans; Levodopa; Middle Aged; Parkinson Disease; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia, Paranoid | 2010 |
Aripiprazole can treat psychotic features but not motor symptoms of Parkinson's disease: evidence from a SPECT study.
Topics: Antipsychotic Agents; Aripiprazole; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Middle Aged; Parkinson Disease; Piperazines; Protein Binding; Psychotic Disorders; Quinolones; Tomography, Emission-Computed, Single-Photon | 2011 |
[Aripiprazole-induced parkinsonism in a 64-year-old female patient diagnosed with bipolar disorder].
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Female; Humans; Middle Aged; Parkinson Disease; Piperazines; Quinolones | 2011 |
[Potentiation of Aripiprazole extrapiramidal adverse effects with the concomitant use of serotonin selective reuptake inhibitors].
Topics: Adult; Antipsychotic Agents; Aripiprazole; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Parkinson Disease; Parkinson Disease, Secondary; Piperazines; Quinolones; Selective Serotonin Reuptake Inhibitors | 2011 |
Aripiprazole and Parkinson's disease psychosis.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Dopamine Agonists; Dose-Response Relationship, Drug; Humans; Levodopa; Male; Parkinson Disease; Piperazines; Psychoses, Substance-Induced; Quinolones | 2004 |
Aripiprazole in psychosis associated with Parkinson's disease.
Topics: Aged; Antipsychotic Agents; Aripiprazole; Female; Humans; Male; Mental Disorders; Middle Aged; Parkinson Disease; Piperazines; Psychiatric Status Rating Scales; Quinolones | 2005 |
Aripiprazole associated with severe exacerbation of Parkinson's disease.
Topics: Antipsychotic Agents; Aripiprazole; Dyskinesia, Drug-Induced; Female; Humans; Middle Aged; Neurologic Examination; Parkinson Disease; Parkinsonian Disorders; Piperazines; Psychotic Disorders; Quinolones | 2006 |
Open-label flexible-dose pilot study to evaluate the safety and tolerability of aripiprazole in patients with psychosis associated with Parkinson's disease.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Parkinson Disease; Pilot Projects; Piperazines; Psychiatric Status Rating Scales; Psychotic Disorders; Quinolones; Severity of Illness Index; Time Factors | 2006 |
Does aripiprazole have a role in treating cognitive impairment in Parkinson's disease?
Topics: Acetylcholine; Antipsychotic Agents; Aripiprazole; Cognition Disorders; Drug Administration Schedule; Humans; Male; Middle Aged; Parkinson Disease; Piperazines; Quinolones; Serotonin | 2007 |
The selective dopamine D1 receptor agonist A-86929 maintains efficacy with repeated treatment in rodent and primate models of Parkinson's disease.
Topics: Analysis of Variance; Animals; Antiparkinson Agents; Dopamine Agonists; Dose-Response Relationship, Drug; Macaca nemestrina; Male; Parkinson Disease; Pyridines; Quinolones; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Rotation; Tetrahydronaphthalenes; Thiophenes | 1997 |
The role of striatal glutamate receptors in models of Parkinson's disease.
Topics: Animals; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Electromyography; Excitatory Amino Acid Antagonists; Haloperidol; Kynurenic Acid; Parkinson Disease; Quinolones; Rats; Receptors, N-Methyl-D-Aspartate; Reserpine | 1998 |